Skip to content Skip to footer
Subscribe Now
PharmaShots Interview In Conversation with Leonard A. Farber and James Welsh, Where they Share Insights on How Nanoparticle can Trigger an Immune Priming Effect
VIEWPOINTS
PharmaShots Interview: In Conversation with Leonard A. Farber and James Welsh, Where they Share Insights on How Nanoparticle can Trigger an Immune Priming Effect
Shots:Leonard spoke about the newly developed radiotherapy-activated nanoparticle and other cancer therapies developing in Nanobiotix’s pipelineJames shared his views on the data presented at the 2022 Annual Meeting of the American Association of Cancer ResearchThe interview provides a core understanding of Nanobiotix’s outlook to expand the utility of nanoparticles in cancer treatment…
June 15, 20220Comments
ThoughtSpot_Saurabh Chaubey
THOUGHTSPOT
Bio-Metaverse: The Inception of New Digital Healthcare
INTRODUCTIONThe next generation of internet-Metaverse is a combination of Virtual Reality (VR), Augmented Reality (AR), Artificial Intelligence (AI), and ever-increasing connectivity (like 5G networks) to create a more immersive, experimental, and interactive online worlds. The metaverse originated by converging three major technical trends- Telepresence (allowing the virtual presence of people even if they are…
June 14, 20220Comments
ThoughtSpot_Senior Editor
THOUGHTSPOT
4 Benefits of Shadowing a Doctor
Becoming a doctor isn’t an easy career to get into. To say that it's very challenging to be one is an understatement. But before you officially become a doctor, you must complete many hours of rigorous training and study. Nevertheless, it’ll be all worth it in the end.If you’ve decided on becoming a doctor…
June 13, 20220Comments
PharmaShots Interview In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development Programs
VIEWPOINTS
PharmaShots Interview: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development Programs
Shots:Ian spoke about the study design of the clinical trials of its lead iNKT agonistsHe also emphasized the advancement of novel immunotherapies through new collaborations The interview provides a gist of Portage's development plan for its pipeline and various options to improve cancer treatmentSmriti: Explain the details (MOA, ROA, formulations, etc.) of PORT-2 & PORT-3?…
June 8, 20220Comments
PharmaShots Interview In Conversation with Cidara’s CEO, Dr.Jeff Stein, Where he Shares Insights on the IND acceptance by the FDA to Treat Influenza
VIEWPOINTS
PharmaShots Interview: In Conversation with Cidara’s CEO, Dr.Jeff Stein, Where he Shares Insights on the IND acceptance by the FDA to Treat Influenza
Shots:Jeff spoke about IND acceptance by the US FDA for its lead flu drug-Fc conjugate immunotherapy for the prevention and treatment of InfluenzaHe also discussed Cidara’s collaboration with Janssen Pharmaceuticals to develop and commercialize Cidara’s DFCsThe interview also emphasizes Cidara’s Cloudbreak platform to develop immunotherapeutic antivirals and treatment options for influenzaSmriti:…
June 6, 20220Comments